Subsidiary of Diet Plan Marketer Medifast Inc. to Pay $3.7 Million to Settle FTC Charges

Unsupported Weight-Loss Claims Violated Previous Order, Agency Alleges

Washingto, DC–(ENEWSPF)–September 10, 2012.  A subsidiary of diet plan marketer Medifast Inc. will pay a $3.7 million civil penalty to settle Federal Trade Commission charges that it violated a previous agency order by making unsupported claims about its weight-loss program.

Medifast unit Jason Pharmaceuticals, Inc. has agreed to settle FTC chargesthat weight-loss claims in the company’s advertisements for meal replacement products violated a 1992 FTC settlement…